Efficacy and safety of endostar in the treatment of advanced lung squamous cell carcinoma.

被引：0
|
作者：
Hu, Weiheng
Fang, Jian
Nie, Jun
Dai, Ling
Zhang, Jie
Chen, Xiaoling
Ma, Xiangjuan
Tan, Guangming
Wu, Di
Han, Jindi
Han, Sen
Wang, Yang
Long, Jieran
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e20574
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20574
引用
收藏
页数：5
相关论文
共 50 条
  • [11] Efficacy and safety of low-dosage apatinib monotherapy in advanced lung squamous cell carcinoma
    Geng, Qian
    Wang, Mengjie
    Lu, Yingzhi
    Zhu, Wenyu
    Sun, Zhiqiang
    Jiang, Hua
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [12] The overall safety and short-term efficacy of nivolumab plus ipilimumab for advanced esophageal squamous cell carcinoma.
    Shiraishi, Kazuhiro
    Yamamoto, Shun
    Yoshinami, Yuri
    Ohara, Akihiro
    Itoyama, Mai
    Yokoyama, Kazuki
    Honma, Yoshitaka
    Kashiraha, Tairo
    Kurita, Daisuke
    Ishiyama, Koshiro
    Oguma, Junya
    Igaki, Hiroshi
    Daiko, Hiroyuki
    Kato, Ken
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 329 - 329
  • [13] CONTINUOUS ADMINISTRATION OF ENDOSTAR PLUS GP CHEMOTHERAPY IN LOCAL ADVANCED OR METASTATIC LUNG SQUAMOUS CELL CARCINOMA
    Shen, Hong
    Zhao, Jing
    Weng, Shan-Shan
    Fang, Xue-Feng
    Zhang, Yi-Yang
    Huang, Jian-Jin
    ACTA MEDICA MEDITERRANEA, 2016, 32 (01): : 57 - 62
  • [14] Clinical efficacy and safety of apatinib as maintenance treatment in patients with advanced esophageal squamous cell carcinoma
    Liu, Guohui
    Wang, Yanbo
    Wang, Chunbo
    He, Yunlong
    Mingyan, E.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (12) : 1423 - 1430
  • [15] Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer
    Dong, Xiaorong
    Zhang, Ruiguang
    Goa, Xican
    Liu, Pian
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S933 - S934
  • [16] Efficacy and safety of Endostar combined with vinorelbine and cisplatin for the treatment of advanced non-small cell lung cancer: a comparative study
    Guo, Jun-Cheng
    Yang, Yi-Jun
    Guo, Min
    Jiang Xiang-Ling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06): : 6062 - 6069
  • [17] Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504)
    Khan, S.
    Sun, Z.
    Pillai, R.
    Dahlberg, S.
    Malhotra, J.
    Keresztes, R.
    Ikpeazu, C.
    Ma, P.
    Ramalingam, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S131 - S132
  • [18] Efficacy and Safety of Glembatumumab Vedotin in Patients With Advanced or Metastatic Squamous Cell Carcinoma of the Lung (PrECOG 0504)
    Khan, Saad A.
    Sun, Zhuoxin
    Dahlberg, Suzanne
    Malhotra, Jyoti
    Keresztes, Roger
    Ikpeazu, Chukwuemeka
    Ma, Patrick
    Ramalingam, Suresh S.
    Pillai, Rathi
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (05):
  • [19] The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
    Shiraishi, Kazuhiro
    Okada, Mao
    Yamamoto, Shun
    Matsubara, Yuki
    Masuishi, Toshiki
    Shimozaki, Keitaro
    Yamamoto, Yoshiyuki
    Hirose, Suguru
    Sugiyama, Keiji
    Furuta, Mitsuhiro
    Machida, Nozomu
    Takahashi, Naoki
    Yoshii, Takako
    Kito, Yosuke
    Tsuzuki, Takao
    Boku, Shogen
    Tsuchihashi, Kenji
    Sugaya, Akinori
    Takayama, Toshizo
    Komori, Azusa
    Mitani, Seiichiro
    Matsumoto, Toshihiko
    Nishimura, Takashi
    Hirata, Kenro
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [20] Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma.
    Raj, Nitya Prabhakar
    Zheng, Youyun
    Kelly, Virginia
    Katz, Seth
    Chou, Joanne F.
    Do, Richard K. G.
    Capanu, Marinela
    Zamarin, Dmitriy
    Ariyan, Charlotte Eielson
    Untch, Brian R.
    O'Reilly, Eileen Mary
    Gopalan, Anuradha
    Berger, Michael F.
    Olino, Kelly
    Segal, Neil Howard
    Reidy, Diane Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345